A carregar...
Nanocomposite Microparticles (nCmP) for the Delivery of Tacrolimus in the Treatment of Pulmonary Arterial Hypertension
Tacrolimus (TAC) has exhibited promising therapeutic potential in the treatment of pulmonary arterial hypertension (PAH); however, its application is prevented by its poor solubility, instability, poor bioavailability, and negative systemic side effects. To overcome the obstacles of using TAC for th...
Na minha lista:
| Publicado no: | Int J Pharm |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5030191/ https://ncbi.nlm.nih.gov/pubmed/27568494 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpharm.2016.08.047 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|